Biochemical Alterations of Stored Erythrocyte Membranes
Completed
- Conditions
- Coagulation
- Registration Number
- NCT02639780
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
The investigators will define procoagulant properties of packed red blood cells and investigate whether packed red blood cells from certain donor populations are prone to induce procoagulant states.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- group 1: healthy female volunteers 18-35 y.o.
- group 2: healthy male volunteers 18-35 y.o.
- group 3: healthy female volunteers 36-60 y.o.
- group 4: healthy male volunteers 36-60 y.o.
- group 5: female volunteers 36-60 y.o., BMI 26-45
- group 6: male volunteers 36-60 y.o., BMI 26-45
Exclusion Criteria
- age below 18 years
- age above 60 years
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method protein expression pattern week 6
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular changes in erythrocyte membranes contribute to procoagulant states during storage?
How do donor population characteristics affect the procoagulant potential of stored packed red blood cells?
What biomarkers correlate with procoagulant properties of erythrocytes in transfusion medicine?
Are there specific protein expression patterns in RBCs that predict coagulation risks post-transfusion?
What strategies mitigate procoagulant effects of stored erythrocytes in clinical transfusion settings?
Trial Locations
- Locations (1)
Medical University of Vienna
🇦🇹Vienna, Austria
Medical University of Vienna🇦🇹Vienna, Austria
